GlobeVerge
INDIA
Natco Pharma Q1 Profit Slumps 57 Per Cent To ₹206.5 Crore On Weak Lenalidomide Sales
Natco Pharma Q1 Profit Slumps 57 Per Cent To ₹206.5 Crore On Weak Lenalidomide Sales
Read it at Free Press JournalMore in Finance
- West Bank: Washington condemns siege of Palestinian homes
- TV channels can now run more than 12 minutes of ads under new rules
- Telangana govt extends HILT policy deadline to Oct 31 amid poor industry response
- Ali Mohammad, Nikhat Banu clinch singles titles at Telangana State-rank table tennis tournament